跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
FAMPYRA
Authorized
STANDARD
FAMPYRA
ACORDA THERAPEUTICS IRELAND LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c2e012cc2811014f
Company
ACORDA THERAPEUTICS IRELAND LIMITED
Type
Standard
Approval Details
Approval Id
c2e012cc2811014f
Drug Approval Canada Name
FAMPYRA
Product Name
FAMPYRA
Status
Marketed
Status Date
2024-10-29
Original Market Date
2012-02-24
Din
02379910
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:56.00
Atc Original
N07XX07 FAMPRIDINE
Atc Name
n 07 xx 07
Aig Number
0153090001
Company Name
ACORDA THERAPEUTICS IRELAND LIMITED
Company Address
10 Earlsfort Terrace, Dublin 2, --, Ireland, D02 T38
Company Detail Path
/organization/acorda-therapeutics-ireland-limited
Company Information
Pharmaceutical Company Name
ACORDA THERAPEUTICS IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
10 Earlsfort Terrace
Active Ingredients
FAMPRIDINE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c2e012cc2811014f
Type
Standard
Back to Health Canada Approvals
FAMPYRA - Health Canada Drug Approval Details